内镜联合部分脾栓塞与Hassab手术治疗肝硬化食管静脉曲张出血伴脾功能亢进的多中心倾向评分匹配队列研究
本研究纳入328例肝硬化食管静脉曲张出血伴脾功能亢进患者,比较内镜治疗联合部分脾栓塞(EP)与Hassab手术(SH)的疗效。倾向评分匹配后每组110例,EP组6个月出血率低于SH组(1.8% vs. 10.0%,P=0.010),但1、2、5年出血率及死亡率无显著差异。
要点
- EP组6个月出血率显著低于SH组(1.8% vs. 10.0%,P=0.010)。
- 两组1、2、5年出血率及死亡率无显著差异。
- 围术期并发症两组无显著差异(0% vs. 3.6%,P=0.008)。
核心结论
- 与SH治疗相比,EP治疗6个月出血率更低,但长期出血率相似。
研究设计与样本
- 多中心队列研究,纳入328例患者,EP组125例,SH组203例,倾向评分匹配后每组110例。
主要发现
- EP组和SH组中位随访时间分别为53个月和64个月。
- EP组6个月出血发生率低于SH组(1.8% vs. 10.0%,P=0.010)。
- 两组1年出血率无显著差异(7.3% vs. 12.7%,P=0.157)。
- 两组2年出血率无显著差异(10.9% vs. 16.4%,P=0.205)。
- 两组5年出血率无显著差异(30.6% vs. 31.8%,P=0.801),死亡率无显著差异(4.5% vs. 7.3%,P=0.571)。
临床怎么用
- 对于肝硬化食管静脉曲张出血伴脾功能亢进患者,EP可作为SH的替代选择,尤其关注短期出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognosis comparison between endoscopic therapy + partial splenic embolization (PSE) and Hassab's operation is unclear in the treatment of esophageal variceal bleeding in patients with liver cirrhosis. This study aimed to compare the outcome of endoscopic therapy + PSE (EP) with a combination of splenectomy + pericardial devascularization procedure, known as Hassab's operation (SH) for esophageal variceal bleeding in patients with liver cirrhosis with hypersplenism. METHODS: We enrolled 328 patients, including 125 and 203 patients who underwent EP and SH, respectively. Each group consisted of 110 patients after propensity score matching (PSM). Subsequently, we recorded and analyzed bleeding episodes and mortality in 6 months and 1, 2, and 5 years after therapies. RESULTS: The median follow-up time in the EP and SH groups was 53 and 64 months, respectively. Bleeding incidence 6 months after therapies in the EP group was lower than that in the SH group (1.8% vs. 10.0%, P = 0.010). Additionally, complications in the perioperative period were not significantly different (0% vs. 3.6%, P = 0.008). However, the bleeding rate between the two groups was not significantly different at 1, 2, and 5 years after therapies (7.3% vs. 12.7%, P = 0.157; 10.9% vs. 16.4%, P = 0.205; 30.6% vs. 31.8%, P = 0.801), as well as mortality rate (4.5% vs 7.3%, P = 0.571). CONCLUSION: Compared with SH therapy, the bleeding rate 6 months after EP therapy was lower, but the long-term bleeding rate was similar.
引用
- Li J, Wei M, Zeng Y, et al. Efficacy of endoscopic therapy combined with partial splenic embolization versus Hassab's operation for patients with liver cirrhosis with esophageal variceal bleeding and hypersplenism: a multicenter cohort study based on propensity score matching. Surg Endosc. 2024. PMID: 39138685. doi:10.1007/s00464-024-11148-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。